SJ Rimmer, MK Church - Clinical and experimental allergy: journal of …, 1990 - ncbi.nlm.nih.gov 1: Clin Exp Allergy. 1990 Aug;20 Suppl 2:3-17. The pharmacology and mechanisms
of action of histamine H1-antagonists. Rimmer SJ, Church MK. Immunopharmacology
Group, Southampton General Hospital, UK. Publication ... Cited by 58 - Related articles - All 3 versions
VM Riccardi - Archives of Dermatology, 1987 - archderm.highwire.org Page 1. Mast-Cell Stabilization to Decrease Neurofibroma Growth Preliminary
Experience With Ketotifen Vincent M. Riccardi, MD \s=b\ Based on (1) the large
numbers of mast cells present in neurofibromas, (2) the possibility ... Cited by 58 - Related articles - All 4 versions
F Simons - Journal of Allergy and Clinical Immunology, 1992 - Elsevier Most first-generation and second-generation H 1 -receptor antagonists have readily demonstrable
antiallergic effects in vitro, although high concentrations of some of the medications are required
to inhibit mediator secretion from mast cells or basophils. These antiallergic effects can ... Cited by 45 - Related articles - All 3 versions
G Marone, G Spadaro, F Granata, M Triggiani - Leukemia research, 2001 - Elsevier Mastocytosis is a rare, heterogeneous disorder characterized by a marked increase in mast cell
density in various tissues. Mast cells from different human tissues are heterogeneous. So far,
there is no cure for systemic mastocytosis. Conventional therapy is based on agents that ... Cited by 39 - Related articles - BL Direct - All 17 versions
GC Francos, YC Kauh, SD Gittlen, ES Schulman, A … - Int J …, 1991 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 39 - Related articles - All 3 versions
VM Riccardi - Archives of Dermatology, 1993 - archderm.highwire.org Page 1. A Controlled Multiphase Trial of Ketotifen to Minimize Neurofibroma-Associated
Pain and Itching Vincent M. Riccardi, MD \s=b\ Background and Design.\p=m-\Based
on potential contribu- tions of mast cells to neurofibroma ... Cited by 36 - Related articles - BL Direct - All 4 versions
NA Orfan, RS Stoloff, KE Harris, R … - Allergy and Asthma …, 1992 - ingentaconnect.com ABSTRACT Idiopathic anaphylaxis (fA) is defined as anaphylaxis with no identifiable precipitating
agent or event. Episodes of IA can be life threatening, and onset of episodes is unpredictable
and usually recurrent. The epidemiologic features and clinical course of 225 patients ... Cited by 30 - Related articles - All 2 versions
I Tillie-Leblond, P Gosset, A Janin, R Dalenne, M … - Journal of Allergy and …, 1994 - Elsevier Primary cold urticaria (PCU) characterized by the association of urticaria, angioedema, and sometimes
a shock-like reaction after cold exposure, is usually considered to be linked with histamine and
prostaglandin D 2 release by mast cells. To determine the involvement of cytokines, we ... Cited by 25 - Related articles - BL Direct - All 3 versions
BL Gruber, LD Kaufman - Arthritis Care & Research - interscience.wiley.com To determine the efficacy of the mast cell-stabilizing drug ketotifen in scleroderma, we conducted
a 6-month, randomized, prospective, double-blind, placebo-controlled trial in 24 patients. No
significant improvement in the clinical paramenters, pulmonary function, global ... Cited by 27 - Related articles - All 3 versions
EW Monroe - Current Problems in Dermatology, 1993 - Elsevier Urticaria is a common cutaneous vascular reaction pattern, with 15% to 20% of the population
having this problem during their lives. Urticaria is characterized by transient, pruritic,
edematous, lightly erythematous papules or wheals, frequently with central clearing. ... Cited by 24 - Related articles - All 2 versions
